As Mayo Clinic builds a collection of scientific instruments based mostly on affected person information, it’s seeking to new options to handle that information.
The well being system and Normal Catalyst lately co-led a $24 million funding in TripleBlind, a startup whose analytics platform permits corporations to collaborate with out having to share uncooked information.
The Kansas Metropolis-based startup says the information by no means leaves its supply, and builders’ algorithms additionally stay encrypted.
As a substitute of manually de-identifying information, equivalent to eradicating data on ages and genders, TripleBlind encrypts it and solely permits the information for use one time by the suitable entity. For instance, a healthcare firm may permit a pharmaceutical firm to run an analytics operation one time, and solely utilizing the data mandatory for that job, CEO Riddhiman Das mentioned.
“If you happen to by no means have the information, you’re implicitly offering higher safety,” he mentioned.
He sees it as a possibility to hurry up innovation in healthcare, by making it simpler to share information, and supply it in a extra well timed method.
Mayo Clinic Platform President Dr. John Halamka, who has been heading up a number of of Mayo Clinic’s digital well being efforts, will be a part of the startup’s board as an observer.
“Bringing collectively AI algorithms and information in ways in which protect privateness and mental property is among the keys to delivering the following technology of digital medication,” he mentioned in a information launch. “These novel privacy-protected options promise to usher a brand new period of collaboration.”
TripleBlind plans to make use of the funds to assist its expertise’s use by digital well being and biopharma corporations, although it additionally sees some potential use circumstances in banking and monetary providers.
Picture credit score: Traitov, Getty Photographs